Akebia Therapeutics | AKBA - 流动资产



金融业
股票价格
USD
资产
USD 362.52M
现金及等价物
USD 162.64M
销售成本
USD 10.34M
流动资产
USD 243.48M
流动负债
USD 173.88M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 27.38M
销售毛利
USD 47.28M
债务利息支出
362.52M
贷款资金
USD 36.4M
市值
USD 259.6M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13M
贸易债权人
USD 8.39M
应收帐款人
USD 47.03M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Celltrion KRW 470.6B 5.07T 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 59.17B 3.55B 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 273.45M 9.96M 2026-03
Prothena USD 339.2M 24.01M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Qiagen NV USD 2B 535.87M 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03